(Q39369722)

English

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Umesh T Sankpal

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Maen Abdelrahim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sarah F Connelly

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Chris M Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Rafael Madero-Visbal

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jimmie Colon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Joshua Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Stephen Safe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pius Maliakal

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Riyaz Basha

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

2 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1648-1658

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Protective effects of green tea against prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Aspirin, salicylates, and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Gastrointestinal tolerance studies on tolfenamic acid in humans and animals

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Regulation of the activity of Sp1-related transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Nuclear receptor-mediated transactivation through interaction with Sp proteins

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

An in vitro FluoroBlok tumor invasion assay.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Targeting Sp1 transcription factors in prostate cancer therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Cell cycle checkpoints and their inactivation in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Androgen receptor signaling in androgen-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Prostate cancer and the met hepatocyte growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and Sp3 regulate basal transcription of the survivin gene

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

PI3K/Akt signalling pathway and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Metastasis: a therapeutic target for cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Matrix metalloproteinases and tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Membrane type-matrix metalloproteinases and tumor progression.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Identifiers

10.1002/PROS.22518

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39369722&oldid=1856162202"